TWIN STUDIES

Short Notes for MDS University Theory Examination

1. DEFINITION

2. RATIONALE / BASIS OF TWIN STUDIES

• "The comparison of disease occurrence or severity in identical (monozygotic) versus nonidentical (dizygotic) twins is a powerful method for distinguishing between effects caused by variation in genes versus factors in the environment."
• This requires the assumption that "the environments of pairs of identical twins are no more or less similar than the environments shared by pairs of nonidentical twins."

3. TYPES OF TWINS

4. KEY CONCEPTS AND TERMINOLOGY

4.1 Concordance

• Definition: "The probability that a pair of individuals (e.g., twins) both have a certain characteristic (e.g., periodontal disease), given that one of the pair has the characteristic. Presented as a number from 0 to 1 or as a percentage." (Newman & Carranza's 14th Ed., Chapter 9 Glossary)

"It was shown that for most applications, the proband-wise rate is the more accurate in genetic twin studies." (McGue 1992, cited in Lindhe 6th Ed.)

4.2 Heritability

• "Genetic epidemiologists calculate a measure called heritability that is based on these correlations and that estimates the portion of all variation in the trait attributable to inherited genetic variation."
• Traits determined entirely by environmental differences have heritabilities of zero.
• Traits attributable solely to inherited genetic differences have heritabilities of 1.0 (also expressed as 0-100%).
• "Most human disease and nondisease traits fall in the middle of this range, with heritability ranging from 0.25 to 0.75."
• Example: Type 2 diabetes - heritability estimated at 0.26; abnormal glucose tolerance - 0.61.

5. LOGIC OF TWIN STUDY METHOD

TWIN STUDY LOGIC
                        |
            ____________|____________
            |                        |
     If disease variation             If disease variation
     caused ENTIRELY by               has a GENETIC
     ENVIRONMENT                      component
            |                        |
  MZ twins = DZ twins              MZ twins are MORE
  (no more similar to              SIMILAR to each other
  each other in disease            than DZ twins in
  risk)                            disease occurrence
            |                        |
     ________|________          ______|______
     |                |        |             |
 Both twin types     Only   High MZ         Low MZ-DZ
 equally similar    family  concordance     difference
 (shared family     factors
 environment)

• All twins (whether identical or nonidentical) are expected to be more similar to their co-twins than to unrelated members of the local population because they were raised in the same family environment with similar diets, microbial exposures, etc.
• However, if genetic variation plays an important role: genetically identical (MZ) twin pairs will be MORE similar to each other than nonidentical (DZ) twin pairs.

6. TWIN STUDIES IN PERIODONTAL DISEASE

6.1 Feasibility Issue

• "For it to be feasible to use the twin method with adequate statistical power, the disease has to be fairly common so that the researcher can recruit enough twin pairs in which at least one of the twins is affected."
• "With regard to periodontal disease, only chronic periodontitis occurs frequently enough to have been studied using the twin design."
• Because aggressive periodontitis occurs so rarely, "it is not feasible to perform a twin study to confirm the heritability of this condition."

• "Severe, early-onset forms of periodontitis, such as aggressive periodontitis, for which it is believed that genetic factors are particularly important in influencing disease susceptibility, have a comparatively low prevalence in the general population and it is very difficult to identify enough affected MZ twins to provide sufficient statistical power."

6.2 Early Study - Ciancio et al. (1969)

• Addressed the concordance of the periodontal condition in twins.
• Study design and low sample numbers (seven MZ and 19 DZ twin pairs ranging in age from 12 to 17 years) did not allow a clear conclusion on the concordance rate of early-onset periodontitis.

6.3 Twin Studies on Chronic Periodontitis - Heritability Data

• Studies of 110 pairs and 117 pairs have been reported.
• These estimate the heritability of measures of chronic periodontitis to range from 40% to 80%, "thereby clearly implicating genetic variation in disease risk."

6.4 Twin Studies on Early-Onset / Aggressive Periodontitis

• Database of 4908 twin pairs.
• Mean age at diagnosis of periodontitis in these twins: 31 years.
• Total of 349 twins reported a history of periodontal disease.
  • 116 were MZ twins; 233 were DZ twins.
  • 70 twins were concordant.

"A twin pair was considered to be concordant if information was provided by one or both pair members and indicated that both pair members were affected."

• Higher concordance rate in MZ twins (0.38) compared to DZ twins (0.16).
• This indicated a higher similarity for the disease phenotype in MZ twins.
• The mean age difference at diagnosis for concordant MZ twin pairs: 1 year; for concordant DZ twin pairs: 5.4 years.
• "The relatively small mean age difference at diagnosis for the MZ twins may also point to an influence of genetic factors on the time of onset of periodontal disease."

6.5 Twin Study on Heritability - Michalowicz et al. (2000)

• Population-based twin study on 117 twin pairs (mean age 40.3 years).
  • Including 63 MZ and 33 DZ twin pairs reared together.
  • And 14 MZ twin pairs reared apart.
• "Showed that the investigated MZ twins (64 pairs) were more similar than the DZ twins (53 pairs) for all investigated measures."
• "Study of identical twins who were raised apart indicates that between 38% and 80% of the variation in [periodontal measures] is attributed to genetic factors."

6.6 Twin Study on Subgingival Bacteria

• A study of bacteria associated with periodontitis found no difference between identical versus nonidentical twins in terms of bacterial composition.
• "This suggests (at least for these twins, most of whom did not have severe periodontitis) that inherited variation in risk is not mediated by genes that influence the presence of specific bacteria in subgingival plaque."

6.7 Twin Studies and Familial Aggregation

• "Periodontal disease has been found in different family members (twins, siblings) and generations of one family. Early twin studies suggested the involvement of genetic susceptibility factors in the etiopathogenesis of periodontitis."
• "The prevalence of aggressive and chronic periodontitis has been investigated in families with a history of one or more family members with periodontitis."
• "The data from those studies showed variable results with a likelihood for heritability of up to 50%. Variations are mainly due to different study designs as well as the number of evaluated individuals."

• Family aggregation data "may also reflect exposure to common lifestyle factors like oral hygiene, diet, and smoking."
• "Certain infectious agents may also cluster in families."
• "Segregation studies with human families are hampered by various methodologic factors, which often are the lack of adequate statistical power due to small numbers of families, too small or incomplete families, and a high heterogeneity between families."

7. TWIN STUDIES - LIMITATIONS

1. Requires large sample size - disease must be common enough to recruit adequate numbers.
2. Aggressive periodontitis - too rare for feasible twin study design.
3. The assumption of equal environments between MZ and DZ twins may not always hold.
4. Incomplete penetrance - "A genetic mutation may not have complete penetrance, and environmental conditions may contribute to the development of the disease (e.g., one twin may smoke and the other may not)."
5. Polygenic diseases - "Many diseases are polygenic (i.e., caused by alterations in multiple genes)," making interpretation more complex.
6. Discordance in MZ twins can be due to epigenetic differences.

8. TWIN STUDIES IN CONTEXT OF GENETIC RESEARCH HIERARCHY

GENETIC RESEARCH HIERARCHY IN PERIODONTOLOGY
                        |
          ______________|______________
          |             |              |
   FAMILY          TWIN STUDIES    MOLECULAR
   AGGREGATION    (MZ vs DZ)       STUDIES
   STUDIES                         (SNPs, GWAS)
          |             |              |
   Shows familial   Quantifies     Identifies
   clustering       heritability   specific genes
          |
   Cannot distinguish
   genetic from
   shared environment
                        |
               TWIN STUDIES ARE THE
               PREFERRED METHOD to
               prove genetic contribution
               over environmental factors

9. SUMMARY TABLE: KEY DATA FROM TWIN STUDIES IN PERIODONTOLOGY

10. CLINICAL SIGNIFICANCE

• Twin studies firmly establish a significant genetic component to the susceptibility to chronic periodontitis.
• The heritability of 40-80% for chronic periodontitis means that 20-60% of the variation is attributable to environmental and behavioral factors (modifiable).
• This underpins the concept of risk assessment in periodontal practice: some patients are genetically susceptible, requiring more intensive preventive strategies.
• The lack of genetic difference in subgingival bacteria between MZ and DZ twins suggests that genetic risk is NOT primarily mediated through differences in plaque composition.
• Future periodontal risk tests "may likely combine inherited polymorphisms with oral microbial profiles, and they might also include assays of gene expression or proteomic data measured in saliva or other oral tissues."

1. Newman & Carranza's Clinical Periodontology and Implantology, 14th Ed. - Chapter 9: Precision Dentistry: Genetics and Epigenetics of Periodontitis (Table 9.1 Glossary; text sections)
2. Lindhe & Lang, Clinical Periodontology and Implant Dentistry, 6th Ed. - Chapter 15: Host-Parasite Interactions (Tables 15-2 and 15-3; text sections on twin studies)

All data, definitions, and figures are directly extracted from the uploaded references without modification or external supplementation.

ANTIMICROBIAL PEPTIDES IN PERIODONTICS

Short Notes for MDS University Theory Examination

1. INTRODUCTION AND OVERVIEW

• "Antimicrobial peptides are components of the innate immune response in eukaryotes, providing defense against a wide spectrum of gram-positive and gram-negative bacteria, viruses, and fungi."
• "In the oral cavity, at least 45 different antimicrobial peptides belonging to different biochemical classes are found in the saliva and the gingival crevicular fluid (GCF)."

• AMPs (Antimicrobial Peptides) are also called defensins and are expressed by epithelial cells.
• Gingival epithelial cells express two human β-defensins (hBD-1 and hBD-2).
• A cathelicidin class AMP, LL-37, found in the lysosomes of neutrophils, is also expressed in gingiva.
• "These AMPs are important for determining the outcomes of the host-pathogen interactions at the epithelial barrier."

2. DEFINITION AND BASIC PROPERTIES

• AMPs are "small, polycationic peptides that disrupt bacterial cell membranes and, thereby, directly kill bacteria with broad specificity."
• The different categories of AMPs are defined on the basis of structural homology.
• "Defensins and cathelicidin LL-37, the most studied antimicrobial peptides, are cationic peptides that bind to negatively charged molecules on the microbial cell surface (e.g., LPS in gram-negative bacteria and LTA in gram-positive bacteria), which ultimately depolarize and permeabilize the cell membrane resulting in bacterial cell death."

3. CLASSIFICATION OF ANTIMICROBIAL PEPTIDES

ANTIMICROBIAL PEPTIDES (AMPs) IN PERIODONTICS
                    |
        ____________|____________
        |            |            |
   α-DEFENSINS   β-DEFENSINS  CATHELICIDINS
        |            |            |
 HNP 1-4       hBD 1-4        LL-37
 (Neutrophil   (Epithelial
  derived)      derived)

4. TYPES, SOURCES AND DISTRIBUTION

5. DEFENSINS - DETAILED DESCRIPTION

5.1 Classification Basis

• "Defensins can be classified into α-defensins and β-defensins, based on structural distinctions in the connecting patterns of three disulfide bonds and in the spacing of cysteine residues."
• "Six human α-defensins and four human β-defensins have been extensively characterized."

5.2 α-Defensins

• α-defensins 1-4 are known as "human neutrophil peptides" due to their expression in neutrophils.
• α-defensins 5 and 6 are localized to the mucosal Paneth cells of the small intestine.

5.3 β-Defensins

• β-defensins 1-4 are produced by a variety of epithelial cells throughout the body and are abundantly produced by epithelial tissues within the oral cavity.
• Found in GCF and saliva.

• Some hBDs are constitutively expressed (e.g., hBD-1).
• Others are expressed only in response to cytokines and bacterial products (e.g., gingipains of P. gingivalis).

6. CATHELICIDIN LL-37 - DETAILED DESCRIPTION

• "A third class of AMPs are the cathelicidins, of which LL-37 is expressed in high levels in the junctional epithelium."
• "Like the hBDs, LL-37 has a widespread expression pattern in the mouth; it is found in the salivary glands, the tongue, and the leukocytes, as well as in the connective tissue."
• LL-37 is "another important human defense peptide residing in neutrophils, which can be found in the gingival epithelium."

• "LL-37 is an effective antimicrobial peptide that is synthesized from inactive precursors, and mutations in the Cathepsin C gene hinder cleavage, and therewith, activation of LL-37."
• "Those genetic alterations contribute to the severity and progression of periodontitis (Papillon-Lefèvre syndrome; Haim-Munk syndrome)."
• Patients with Kostmann syndrome (congenital neutropenia) "show reduced levels of antimicrobial peptides, such as the cathelicidin LL-37 and neutrophil peptides (alpha-defensins), which impair their innate immune response."

7. HISTATINS

• Histatins are antimicrobial peptides found in saliva.
• They function by "neutralizing LPS (lipopolysaccharide)" - i.e., they inhibit specific virulence factors.
• Listed as components of the innate immune response alongside beta-defensins and protease inhibitors.

8. ANATOMICAL DISTRIBUTION IN THE PERIODONTIUM

9. AMPs IN THE JUNCTIONAL EPITHELIUM (JE)

• "The JE expresses defensive factors by producing natural antimicrobial peptides and proteins in response to the bacterial challenge, such as β-defensins, cathelicidin LL-37, and calprotectin."
• "Furthermore, the JE constitutively expresses numerous cell adhesion molecules (CAMs) and produces chemokines and cytokines, such as IL-8 and IL-1β."

10. FUNCTIONS OF AMPs - BEYOND ANTIMICROBIAL ACTION

11. GCF COMPONENTS - AMPs AS DEFENSE

1. "Cleansing particles from the sulcus"
2. "Containing antimicrobial peptides"
3. "Exerting antibody activity to defend the host"

• "Human alpha and beta-defensins (hBD)-1,-2,-3 are a family of low-molecular-weight antimicrobial peptides. Produced by a number of cells, including neutrophils, they amplify and combat bacterial infections important to homeostasis."

12. ROLE OF AMPs IN PERIODONTAL DISEASE

• "In the periodontium the expression of β-defensins 1, 2, and 3 is observed at the mRNA level, both in clinically healthy and diseased tissues."
• "The expression of these epithelium-derived peptides appears to be correlated with periodontal health, thereby suggesting a protective role."
• "While the role of defensins and LL-37 in periodontal disease is currently not well understood, the expression of neutrophil-derived α-defensins 1-3 and LL-37 has been reported to be significantly elevated in the GCF of patients with chronic periodontitis."

• "The expression of defensins induced by whole periodontal pathogenic [bacteria]" - i.e., periodontal pathogens can stimulate AMP expression.
• hBDs are expressed in response to cytokines and bacterial products including gingipains of P. gingivalis.

13. FLOWCHART: AMP ACTIVITY MECHANISM

MICROBIAL CHALLENGE
(LPS/gram-negative; LTA/gram-positive)
              |
    __________|__________
    |                    |
EPITHELIAL CELLS    NEUTROPHILS (PMNs)
Produce β-defensins  Produce α-defensins
(hBD 1,2,3)         (HNP 1-4)
+ LL-37              + LL-37
              |
    __________|__________
    |                    |
AMPs BIND to          IMMUNOMODULATORY
NEGATIVELY CHARGED    FUNCTIONS
microbial surface
(LPS/LTA)
              |
    __________|__________
    |                    |
DEPOLARIZE &        Chemotaxis of
PERMEABILIZE        leukocytes
cell membrane
              |
    Bacterial CELL DEATH     Mast cell
                             degranulation
                                  |
                             Cytokine production
                                  |
                             Wound healing /
                             Keratinocyte differentiation

14. SALIVARY AMPs - INNATE DEFENSE COMPONENTS

• Mucins - non-specifically inhibit plaque biofilm formation by inhibiting adherence and promoting agglutination.
• Histatins - inhibit specific virulence factors (neutralize LPS).
• Lactoferrin - inhibits bacterial cell growth; effective against Actinobacillus species.
• Beta-defensins - epithelial-cell derived; in saliva.
• Protease inhibitors - present alongside AMPs.

15. BACTERIOCINS - RELATED ANTIMICROBIAL PEPTIDES

• Certain commensal bacteria in the oral cavity use "their bacteriocins (secreted antimicrobial peptides) to suppress periodontal pathogens in biofilms and in planktonic forms."
• S. mutans produces antimicrobial peptides "that have broad activity against bacteria in vitro."
• Probiotics using commensal bacteria could be designed to deliver bacteriocins, other small antimicrobial peptides, molecules, or prebiotics to suppress periodontal pathogens.

16. THERAPEUTIC IMPLICATIONS OF AMPs

• "The antimicrobial and immunomodulatory roles of defensins also have obvious attractiveness for therapeutic applications."
• Limitation: "However, the biochemical purification process is cost-inefficient and the synthesis process is complicated by the size and tridimensional structure of the peptides."
• Novel analogs: "Recently, novel analogs of defensins have shown even higher antibacterial activity than the endogenous β-defensins 1 and 3, without any cytotoxic effects on host cells, thus indicating the promise of this approach."
• Future therapeutic applications include "customized therapies" using antimicrobial peptides particularly beneficial for select patients identified based on genomic information.

17. CLINICAL SIGNIFICANCE IN SPECIFIC CONDITIONS

Papillon-Lefèvre Syndrome and Haim-Munk Syndrome

• Mutations in the Cathepsin C gene → hinder cleavage and activation of LL-37 → impaired innate immune response → severe aggressive periodontitis.
• "Those genetic alterations contribute to the severity and progression of periodontitis."

Kostmann Syndrome (Congenital Neutropenia)

• "Patients with Kostmann syndrome show reduced levels of antimicrobial peptides, such as the cathelicidin LL-37 and neutrophil peptides (alpha-defensins), which impair their innate immune response."
• Results in increased susceptibility to infection in general and severe periodontitis.

Vitamin D and AMP Production

• "Vitamin D is relevant to the oral virome as it upregulates the production of cathelicidin LL-37 (an antimicrobial peptide) in neutrophils."

18. SUMMARY TABLE: KEY FEATURES OF MAJOR AMPs IN PERIODONTICS

1. Newman & Carranza's Clinical Periodontology and Implantology, 14th Ed. - Chapter 8 (Host-Microbe Interactions), Chapter 11 (Inflammatory Response in the Periodontium - Defensins & Cathelicidin LL-37), Chapter 14 (Junctional Epithelium / GCF), Chapter on Genetic factors
2. Carranza's Clinical Periodontology, 10th Ed. - Chapter 12 (Innate Immunity)
3. Genomics, Personalized Medicine and Oral Disease (uploaded reference) - Therapeutic applications of AMPs

All content extracted exclusively from the uploaded reference documents without external supplementation.

ANTIOXIDANTS IN PERIODONTICS

Short Notes for MDS University Theory Examination

1. INTRODUCTION - OXIDATIVE STRESS AND PERIODONTAL DISEASE

• "Highly reactive oxygen-based molecules, such as the hydroxyl radical, superoxide, and peroxide." (Newman & Carranza's Clinical Periodontology and Implantology, 14th Ed., Chapter 8 - Glossary, Table 8.2)
• "There is evidence of higher serum levels of markers of oxidative stress and of decreased antioxidant capacity in individuals with periodontitis when compared to periodontally healthy controls." (Chapple & Matthews 2007, cited in Lindhe & Lang, Clinical Periodontology and Implant Dentistry, 6th Ed., Chapter 14)
• "Adipokine action and oxidative stress have been proposed to serve as the common link in the pathobiology of obesity and periodontitis." (Bullon et al. 2009, cited in Lindhe & Lang, 6th Ed., Chapter 14)

2. SOURCES OF ROS / FREE RADICALS IN THE PERIODONTIUM

3. DEFINITION AND CONCEPT OF ANTIOXIDANTS

• Vitamins are "defined as essential organic compounds that are catalysts for the body's metabolic reactions; they also function as electron donors, antioxidants, and transcription effectors." (Newman & Carranza's 14th Ed. - Chapter on Pediatric/Adolescent Periodontal Health)
• "Data suggest that diets that contain foods rich in antioxidants are beneficial, whereas foods that contain high levels of refined carbohydrates are detrimental to the inflammatory process." (Newman & Carranza's 14th Ed., Chapter on Nutritional Factors)
• "Various nutrients, such as long-chain omega-3 fatty acids, have been found to have immunomodulatory properties, whereas others act to ameliorate the destructive effects of reactive oxygen species (ROS) functioning as ROS scavengers." (Newman & Carranza's 14th Ed., Chapter 5)

4. CLASSIFICATION OF ANTIOXIDANTS RELEVANT TO PERIODONTICS

5. VITAMIN C (ASCORBIC ACID) - KEY ANTIOXIDANT IN PERIODONTICS

5.1 Basic Properties

• "Vitamin C is a powerful antioxidant radical scavenger that is distributed in many cell types, including polymorphonuclear leukocytes, platelets, and endothelial cells, and which has been shown to exercise effects on osteoclasts and periodontal ligament fibroblasts." (Lindhe & Lang, 6th Ed., Chapter 14)
• Vitamin C is "required for collagen synthesis" - it "induces periodontal ligament differentiation and osteoblast differentiation." (Newman & Carranza's 14th Ed.)

5.2 Historical Significance

• "The effect of ascorbic acid (vitamin C) deficiency on the gingival tissues has been known since the 18th century, when an association between scurvy and bleeding gums and tooth loss was first observed in sailors who did not have access to fresh fruit and vegetables over prolonged time periods." (Lindhe & Lang, 6th Ed., Chapter 14)

5.3 Scurvy and Periodontal Manifestations

• "Severe vitamin C deficiency in humans results in scurvy, a disease characterized by hemorrhagic diathesis and delayed wound healing."
• "Scurvy results in defective formation and maintenance of collagen, impairment or cessation of osteoid formation, and impaired osteoblastic function."
• "Vitamin C deficiency is also characterized by increased capillary permeability, susceptibility to traumatic hemorrhages, hyporeactivity of the contractile elements of the peripheral blood vessels, and sluggishness of blood flow."
• Clinical manifestations include: "Bleeding, swollen gingiva and loosened teeth are common features of scurvy."
• "Severe vitamin C deficiency results in scurvy, and some of the clinical features of scurvy are hyperkeratosis, petechiae, ecchymosis, xerostomia, impaired wound healing, and inflamed and bleeding gums."

5.4 Mechanisms by Which Ascorbic Acid Deficiency Affects Periodontium

1. "Low levels of ascorbic acid influence the metabolism of collagen within the periodontium, affecting the ability of the tissue to regenerate and repair itself."
2. "Ascorbic acid deficiency interferes with bone formation, leading to loss of periodontal bone. Changes that do occur in alveolar bone result from failure of osteoblasts to form osteoid. Osteoporosis of alveolar bone in scorbutic monkeys results from increased osteoclastic resorption and is not associated with periodontal pocket formation."
3. "Ascorbic acid deficiency increases the permeability of the oral mucosa to endotoxin."

5.5 Clinical Relevance

• "The 2017 EFP/ORCA Workshop concluded that dietary counseling on vitamin C and vitamin D intakes should be part of the information provided to our patients and caregivers." (Newman & Carranza's 14th Ed.)
• "Because vitamin deficiency may play a role in the development and progression of periodontitis and gingival bleeding, the 2017 EFP/ORCA Workshop" made the above recommendation.

6. VITAMIN E - ANTIOXIDANT IN PERIODONTICS

6.1 Mechanism

• "Vitamin E serves as an antioxidant to limit free-radical reactions and to protect cells from lipid peroxidation."
• "Cell membranes, which are high in polyunsaturated lipids, are the major site of damage in patients with vitamin E deficiency."

6.2 Periodontal Relevance

• "No relationship has been demonstrated between deficiencies in vitamin E and oral disease."
• However, "systemic vitamin E appears to accelerate gingival wound healing in the rat."

6.3 Therapeutic Application

• "The administration of the combination of pentoxifylline with vitamin E as antioxidant therapy currently shows the greatest promise for revascularization and treatment of osteoradionecrosis sites." (Newman & Carranza's 14th Ed. - Chapter on Management of Medically Compromised Patients)

7. VITAMIN D - ANTIOXIDANT / IMMUNOMODULATORY ROLES

• "While it has long been known that vitamin D and calcium are important for skeletal development and maintenance of bone mass, vitamin D has emerged as an important regulator of innate immune responses in infectious diseases."
• Vitamins also function as "electron donors, antioxidants, and transcription effectors."
• "Clinical studies have demonstrated a significant association between vitamin D's endocrine effects and periodontal disease, where patients with generalized periodontitis have shown significantly elevated vitamin D-binding protein plasma levels."
• "Vitamin D may also have an impact on the periodontal immune response by decreasing interleukin (IL)-8 and IL-6 expression."
• Vitamin D upregulates cathelicidin LL-37 (an antimicrobial peptide) production in neutrophils.

8. ROLE OF ANTIOXIDANTS IN SPECIFIC PERIODONTAL CONTEXTS

8.1 Antioxidants vs. ROS in Necrotizing Periodontal Disease (NPD)

• "In response to periodontal pathogens, phagocytes elaborate destructive oxidants, proteinases, and other factors."
• "Periodontal damage may occur as the result of the interaction between these factors, the antioxidants, and the host-derived antiproteinases."
• "Malnutrition is characterized by marked tissue depletion of the key antioxidant nutrients and impaired acute-phase protein response to infections."

8.2 Antioxidants in Diabetes-Associated Periodontitis

• "Hyperglycemia drives the formation of AGEs and leads to increased expression and activation of their chief receptor RAGE."
• "The AGE-RAGE interaction negatively affects cellular phenotype and function, leading to enhanced inflammation, production of reactive oxygen species or oxidative stress, and compromised tissue repair."
• "Hyperglycemia also promotes oxidative stress directly" - this creates a vicious cycle of inflammatory stress and impaired repair in the diabetic periodontium.

DIABETES - ROS - PERIODONTAL DESTRUCTION PATHWAY
            |
     HYPERGLYCEMIA
            |
    AGE formation
            |
   AGE - RAGE interaction
            |
    ________|________
    |                |
INFLAMMATION   OXIDATIVE STRESS (ROS)
    |                |
    |______|_________|
           |
   Further AGE formation
           |
   IMPAIRED TISSUE REPAIR
           |
   ACCELERATED PERIODONTAL
        DESTRUCTION

8.3 Antioxidants and Tobacco Smoking

• "Due to the consumption of tobacco, reactive oxygen (radicals) is released that chemically irritate periodontal tissues by:
  • DNA damage
  • Lipid peroxidation of cell membranes
  • Damage of endothelial cells
  • Induction of smooth muscle cell growth"

9. DOXYCYCLINE (SUB-ANTIMICROBIAL DOSE) AS AN ROS SCAVENGER - HOST MODULATION

• "Scavenges and inhibits production of reactive oxygen species (ROS) produced by PMNs (e.g., HOCl, which activates latent MMPs)"
• "Inhibition of oxidative activation of latent MMPs (independent of cation-binding properties)"
• "Inhibition of MMPs and ROS protects α1 proteinase inhibitor (α1-PI), thereby indirectly reducing tissue proteinase activity"
• "Direct inhibition of active MMPs by cation chelation (dependent on Ca²⁺ and Zn²⁺ binding properties)"
• "Downregulates expression of key inflammatory cytokines including IL-1, IL-6, and TNF-α as well as PGE₂"
• "Stimulates fibroblast collagen production"
• "Reduces osteoclast activity and bone resorption"
• "Stimulates osteoblast activity and bone formation"

10. NUTRITIONAL SUPPLEMENTATION AND PERIODONTAL THERAPY OUTCOMES

• "In general, epidemiologic studies reveal that periodontitis is associated with low serum/plasma micronutrient levels."
• "While early evidence from interventional studies (Campan et al. 1997; Staudte et al. 2005; Jenzsch et al. 2009; Chapple et al. 2012) suggests that adjunctive nutritional supplementation may result in improved periodontal therapy outcomes."
• "Additional research from randomized placebo-controlled trials is needed to further document these effects and to facilitate the development of nutritional recommendations in the prevention and control of periodontal diseases."

11. ANTIOXIDANTS IN GINGIVAL WOUND HEALING

• Vitamin E: "Systemic vitamin E appears to accelerate gingival wound healing in the rat." (Newman & Carranza's 14th Ed.; Carranza's 10th Ed.)
• Vitamin C: Required for collagen synthesis; deficiency leads to "impaired wound healing."
• Pentoxifylline + Vitamin E combination shows "greatest promise for revascularization and treatment of osteoradionecrosis sites." (Newman & Carranza's 14th Ed.)

12. ANTIOXIDANTS AND GINGIVAL DISEASES MODIFIED BY MALNUTRITION

• "Gingival diseases modified by malnutrition have received attention because of clinical descriptions of bright red, swollen, and bleeding gingiva associated with severe ascorbic acid (vitamin C) deficiency or scurvy."
• "In the absence of frank scurvy, the effect of declining ascorbic acid levels on the gingiva can be difficult to detect clinically, and when it is detected, it usually has characteristics that are similar to plaque-induced gingivitis."
• "The available evidence to support a clinically impactful role for mild nutritional deficiencies in the development or severity of gingival inflammation in humans is limited."

13. SUMMARY TABLE: ANTIOXIDANTS AND THEIR ROLES IN PERIODONTICS

14. FLOWCHART: OXIDATIVE STRESS AND ANTIOXIDANT BALANCE IN PERIODONTICS

MICROBIAL CHALLENGE
        |
  NEUTROPHIL / MACROPHAGE ACTIVATION
        |
   ROS PRODUCTION
   (Hydroxyl radical, Superoxide,
    Peroxide, HOCl)
        |
        |_________________________________
        |                                |
  EXCESS ROS                     ANTIOXIDANT DEFENSE
  (Oxidative stress)              (Vitamins C, E, D;
        |                         Glutathione; Carotenoids;
        |                         Polyphenols; SDD)
        |                                |
   DNA damage                      NORMAL RESOLUTION
   Lipid peroxidation              OF INFLAMMATION
   Protein oxidation               (Periodontal health)
   Collagen degradation
   Endothelial cell damage
        |
  AMPLIFIED INFLAMMATION
        |
  PERIODONTAL TISSUE DESTRUCTION
  (Attachment loss, Bone loss)

15. KEY EXAMINER POINTS TO REMEMBER

1. Chapple & Matthews (2007) - landmark reference showing "higher serum levels of markers of oxidative stress and decreased antioxidant capacity in individuals with periodontitis." (Lindhe 6th Ed.)
2. Vitamin E: No direct relationship demonstrated with oral disease, BUT accelerates gingival wound healing in rats. Pentoxifylline + Vit. E = greatest promise for osteoradionecrosis treatment.
3. Vitamin C: Powerful antioxidant radical scavenger; deficiency → scurvy → periodontal destruction; collagen synthesis; PDL fibroblast function.
4. 2017 EFP/ORCA Workshop: Endorsed dietary counseling on Vitamin C and D as part of patient information.
5. Doxycycline (SDD): Acts as an antioxidant by scavenging HOCl produced by PMNs, inhibiting oxidative activation of latent MMPs - a key host modulation mechanism.
6. Diabetes → AGEs → RAGE → ROS = vicious cycle amplifying periodontal destruction; antioxidants can theoretically interrupt this pathway.
7. Tobacco: Releases reactive oxygen radicals → DNA damage, lipid peroxidation, endothelial damage.
8. Malnutrition/NPD: "Marked tissue depletion of key antioxidant nutrients" is a feature of malnutrition predisposing to necrotizing periodontal disease.
9. Vitamins = electron donors, antioxidants, transcription effectors (Newman 14th Ed. definition).

1. Newman & Carranza's Clinical Periodontology and Implantology, 14th Ed. - Chapters 5, 8, 14, 24, 38, 55
2. Carranza's Clinical Periodontology, 10th Ed. - Chapter on Nutritional Deficiencies and Periodontal Disease
3. Lindhe & Lang, Clinical Periodontology and Implant Dentistry, 6th Ed. - Chapter 14 (Modifying Factors - Nutritional/Metabolic), Chapter on Necrotizing Periodontal Diseases (NPD)
4. Clinical Epidemiology The Essentials, 5th Ed. - Antioxidant confounding example

All content extracted exclusively from the uploaded reference documents, reproduced without paraphrasing, modernization, or external supplementation.

RISK FACTORS, RISK DETERMINANTS AND RISK INDICATORS FOR PERIODONTAL DISEASE

Comprehensive Postgraduate Theory Examination Notes

1. DEFINITIONS - ESSENTIAL TERMINOLOGY

1.1 Disease Risk

• "Disease risk is the probability that an individual will develop a specific disease in a given period. The risk of developing the disease will vary from individual to individual." (Newman & Carranza's 14th Ed., Chapter 40)

1.2 Risk Factor

• "Risk factors may be environmental, behavioral, or biologic factors that, when present, increase the likelihood that an individual will develop the disease."
• "Risk factors are identified through longitudinal studies of patients with the disease of interest."
• "Exposure to a risk factor or factors may occur at a single point in time, over multiple separate points in time, or continuously."
• "However, to be identified as a risk factor, the exposure must occur before disease onset."
• "Interventions often can be identified and, when implemented, can help modify risk factors."

1.3 Risk Determinant / Background Characteristic

• "The term risk determinant/background characteristic, which is sometimes substituted for the term risk factor, should be reserved only for factors that cannot be modified." (Newman & Carranza's 14th Ed., Chapter 40; Carranza's 10th Ed., Chapter 38)

Important Note from Newman 14th Ed.: "Stress is listed as a risk determinant, but it is important to know that unlike other risk determinants listed above, it can be alleviated and hence its negative effect on periodontium can be minimized or negated."

1.4 Risk Indicator

• "Risk indicators are probable or putative risk factors that have been identified in cross-sectional studies but not confirmed through longitudinal studies." (Newman & Carranza's 14th Ed., Chapter 40; Carranza's 10th Ed., Chapter 38)

1.5 Risk Predictor / Risk Marker

• "Risk predictors/markers, although associated with increased risk for disease, do not cause the disease."
• "These factors also are identified in cross-sectional and longitudinal studies." (Newman & Carranza's 14th Ed., Chapter 40; Carranza's 10th Ed., Chapter 38)

1.6 Prognostic Factors vs. Risk Factors

• "Distinction must be made between prognostic factors (disease predictors), that is characteristics related to the progression of pre-existing disease, and true risk factors, that is exposures related to the onset of the disease."
• Example: "The amount of alveolar bone loss or the number of teeth present at baseline may be used to predict further progression of the disease. These variables are, in fact, alternative measures of the disease itself and express the level of susceptibility of a given subject. Although they may be excellent predictors for further disease progression, they clearly cannot be considered as risk factors."

2. MASTER TABLE: CATEGORIES OF RISK ELEMENTS FOR PERIODONTAL DISEASE

3. FLOWCHART: CLASSIFICATION OF RISK ELEMENTS

RISK ELEMENTS FOR PERIODONTAL DISEASE
                    |
    ________________|________________
    |           |           |         |
RISK         RISK        RISK       RISK
FACTORS    DETERMIN-   INDICA-    MARKERS/
           ANTS/BG     TORS       PREDICTORS
CHAR.
    |           |           |         |
Modifiable   Cannot be    Identified  Associated
Identified   modified     in cross-   with risk
in           (mostly)     sectional   but do not
longitudinal             studies;    CAUSE disease
studies                  NOT
                         confirmed
                         longitudinally
    |           |           |         |
Smoking    Genetics    HIV/AIDS  Previous Hx
Diabetes   Age         Osteo-    of perio
Bacteria   Gender      porosis   disease
           SES         Infreq.   BOP
           Stress      dental
                       visits

4. RISK FACTORS FOR PERIODONTAL DISEASE

4.1 TOBACCO SMOKING

• "Tobacco smoking is a well-established risk factor for periodontitis. A direct relationship exists between smoking and the prevalence of periodontal disease. This association is independent of other factors, such as oral hygiene or age." (Carranza's 10th Ed., Chapter 38)
• "The 2004 US Surgeon General report concluded that the evidence was sufficient to infer a causal relationship between smoking and periodontitis." (Newman & Carranza's 14th Ed., Chapter 6)

• "Studies comparing the response to periodontal therapy in smokers, previous smokers, and nonsmokers have shown that smoking has a negative impact on the response to therapy. However, former smokers respond similarly to nonsmokers." (Carranza's 10th Ed., Chapter 38)

• Tobacco use releases reactive oxygen radicals that chemically irritate periodontal tissues by DNA damage, lipid peroxidation of cell membranes, damage of endothelial cells, and induction of smooth muscle cell growth.
• Gingival bleeding is suppressed in smokers, which may mask disease activity. (Newman & Carranza's 14th Ed.)

• PAR% among non-diabetics: 51% (ages 19-30) and 32% (ages 31-40) (Haber et al. 1993). (Lindhe & Lang, 6th Ed., Chapter 7)

4.2 DIABETES MELLITUS

• "Diabetes is a clear risk factor for periodontitis. Epidemiologic data demonstrate that the prevalence and severity of periodontitis are significantly higher in patients with type 1 or type 2 diabetes mellitus than in those without diabetes, and that the level of diabetic control is an important variable in this relationship." (Carranza's 10th Ed., Chapter 38)
• "Periodontitis is known as the sixth complication of diabetes mellitus." (Newman & Carranza's 14th Ed.)

• Formation of Advanced Glycation End Products (AGEs) → AGE-RAGE interaction → enhanced inflammation, ROS production, compromised tissue repair.
• Hyperglycemia promotes oxidative stress directly.
• Increased adipokines influencing inflammatory responses. (Lindhe & Lang, 6th Ed., Chapter 14)

• Patients with diabetes exhibit higher risk to develop periodontitis.
• The periodontal infection/inflammation may negatively interfere with the glycemic control of the diabetic patient.
• Systematic periodontal therapy leads to at least short-term reduction of glycated hemoglobin (HbA1c) of approximately 0.3% to 0.6%. (Newman & Carranza's 14th Ed.)

4.3 PATHOGENIC BACTERIA AND MICROBIAL TOOTH DEPOSITS

• "The quantity of plaque present may not be as important as the quality of the plaque in determining risk for periodontitis." (Carranza's 10th Ed., Chapter 38; Newman & Carranza's 14th Ed., Chapter 40)
• "Often, patients with severe loss of attachment have minimal levels of bacterial plaque on the affected teeth." (Carranza's 10th Ed., Chapter 38)

1. Aggregatibacter actinomycetemcomitans (formerly Actinobacillus actinomycetemcomitans)
2. Porphyromonas gingivalis
3. Tannerella forsythia (formerly Bacteroides forsythus)

Recent Terminology Change: "Actinobacillus actinomycetemcomitans" → Aggregatibacter actinomycetemcomitans; "Bacteroides forsythus" → Tannerella forsythia.

1. Association - found in periodontitis
2. Elimination - "Their elimination or suppression impacts the success of periodontal therapy"
3. Host response - "There is elevated antibody in serum, saliva, or in periodontal tissue to these pathogens"
4. Virulence factor - "Virulence factors (e.g., leukotoxin, endotoxin) are associated with these pathogens"
5. Animal studies - "Inoculation of these bacteria into animal models induces periodontal disease"
6. Risk assessment - "Cross-sectional and longitudinal studies support their delineation as risk factors"

• Furcations, root concavities, developmental grooves, cervical enamel projections, enamel pearls, bifurcation ridges may predispose the periodontium to disease as a result of their potential to harbor bacterial plaque.
• Subgingival and overhanging margins → increased plaque accumulation → increased inflammation and bone loss.
• Presence of calculus (which serves as a reservoir for bacterial plaque) has been suggested as a risk factor, particularly in patients not receiving regular care and those with poorly controlled diabetes. (Carranza's 10th Ed., Chapter 38; Newman & Carranza's 14th Ed., Chapter 40)

5. RISK DETERMINANTS / BACKGROUND CHARACTERISTICS

5.1 GENETIC FACTORS

• "Evidence indicates that genetic differences between individuals may explain why some patients develop periodontal disease and others do not." (Carranza's 10th Ed., Chapter 38)

• "Studies conducted in twins have shown that genetic factors influence clinical measures of gingivitis, probing pocket depth, attachment loss, and interproximal bone height." (Carranza's 10th Ed., Chapter 38)

• Kornman et al. demonstrated that "alterations in specific genes encoding the inflammatory cytokines interleukin-1α and interleukin-1β (IL-1α, IL-1β) were associated with severe chronic periodontitis in nonsmoking subjects."
• Changes in IL-1 genes "may be only one of several genetic changes involved in the risk for chronic periodontitis."
• "Although the alteration in the IL-1 genes may be a valid marker for periodontitis in defined populations, its usefulness as a genetic marker in the general population may be limited."

• Neutrophil abnormalities
• Monocytic hyperresponsiveness to LPS stimulation in patients with localized aggressive periodontitis
• Alterations in monocyte/macrophage receptors for Fc portion of antibody
• Genetics plays a role in regulating the titer of the protective IgG2 antibody response to A. actinomycetemcomitans

• "The familial aggregation seen in localized and generalized aggressive periodontitis is also indicative of genetic involvement in these diseases." (Carranza's 10th Ed., Chapter 38)

5.2 AGE

• Periodontal destruction increases with advancing age.
• "An age-related, rather than an age-dependent, increased susceptibility to periodontitis in older people is therefore biologically plausible."
• "The extent to which this association reflects an age-related or an age-dependent increased susceptibility was found to be attenuated after adjustment for co-variates, such as oral hygiene levels or access to dental care services." (Lindhe & Lang, 6th Ed., Chapter 7)
• NHANES data showing increasing prevalence with each decade of age serves as key epidemiological support. (Newman & Carranza's 14th Ed.; Lindhe & Lang, 6th Ed.)

5.3 GENDER (SEX)

• "There is no established, inherent difference between men and women in their susceptibility to periodontal disease."
• However, men have been shown to exhibit worse periodontal conditions than women in multiple studies.
• This difference has been traditionally considered to reflect better oral hygiene practices and increased utilization of oral health care services among women.
• There is evidence for sexual dimorphism in elements of both innate and acquired immunity leading to enhanced pro-inflammatory responses in men. (Lindhe & Lang, 6th Ed., Chapter 7)

5.4 SOCIOECONOMIC STATUS (SES)

• "Gingivitis and poor oral hygiene can be related to lower socioeconomic status (SES). This can most likely be attributed to decreased dental awareness and decreased frequency of dental visits compared with more educated individuals of higher SES."
• "After adjusting for other risk factors, such as smoking and poor oral hygiene, lower SES alone does not result in increased risk for periodontitis." (Carranza's 10th Ed., Chapter 38)
• Cross-sectional Brazilian study (Peres et al.): Self-reported Black and Brown adults, males, of lower schooling and income have higher prevalence of periodontal diseases than whites, women, and individuals with higher schooling and income. (Oral Epidemiology - Peres et al., cited in Lindhe & Lang 6th Ed.)

5.5 STRESS

• "The incidence of necrotizing ulcerative gingivitis increases during periods of emotional and physiologic stress, suggesting a link between the two."
• "Emotional stress may interfere with normal immune function and may result in increased levels of circulating hormones, which can affect the periodontium."
• "Stressful life events such as bereavement and divorce appear to lead to a greater prevalence of periodontal disease."
• "An apparent association exists between psychosocial factors and risk behaviors such as smoking, poor oral hygiene, and chronic periodontitis."
• "Adult patients with periodontitis who are resistant to therapy are more stressed than those who respond to therapy."
• "Individuals with financial strain, distress, depression, or inadequate coping mechanisms have more severe loss of attachment."
• Epinephrine/norepinephrine from stress "cause hyperglycemia, affect the immune system, and also affect the wound healing process."

• "Although epidemiologic data on the relationship between stress and periodontal disease are limited, stress can be a putative risk factor for periodontitis."
• "Stress is listed as a risk determinant, but it is important to know that unlike other risk determinants listed above, it can be alleviated and hence its negative effect on periodontium can be minimized or negated." (Newman & Carranza's 14th Ed., Chapter 40)

6. RISK INDICATORS FOR PERIODONTAL DISEASE

6.1 HIV / AIDS

• "It has been hypothesized that the immune dysfunction associated with HIV infection and AIDS increases susceptibility to periodontal disease."
• "Early reports on the periodontal status of patients with AIDS or those who are HIV seropositive revealed that these patients often had severe periodontal destruction characteristic of necrotizing periodontitis."
• "More recent reports, however, have failed to demonstrate significant differences in the periodontal status of individuals with HIV infection and healthy controls."
• "Conflicting results also exist in studies examining the level of immunosuppression and severity of periodontal destruction."
• "Evidence also suggests that AIDS-affected individuals who practice good preventive oral health measures, including effective home care and seeking appropriate professional therapy, can maintain periodontal health."
• "Therefore, although it seems reasonable to hypothesize that HIV infection and immunosuppression are risk factors for periodontal disease, the evidence is not conclusive." - This is why it remains a risk INDICATOR and not a confirmed risk factor.

6.2 OSTEOPOROSIS

• "Early cross-sectional studies, of limited sample size and largely confined to post-menopausal women, have suggested that women with low bone mineral density are more likely to have gingival recession and/or pronounced gingival inflammation and clinical attachment loss."
• Persson et al. (2002): "Positive association between osteoporosis and periodontitis with an OR of 1.8 (95% CI 1.2–2.5)" in 1084 subjects aged 60-75 years. (Lindhe & Lang, 6th Ed., Chapter 7)
• "Postmenopausal osteopenia as a risk indicator for periodontal disease in post-menopausal women." (Newman & Carranza's 14th Ed., Chapter 25)
• "Studies that have failed to report such an association have also been published" - hence risk indicator, not confirmed risk factor.

6.3 INFREQUENT DENTAL VISITS

• "A study of risk indicators for a group of 1426 patients between the ages of 25 and 74 revealed that individuals [with infrequent dental visits had higher risk for periodontal disease]." (Newman & Carranza's 14th Ed., Chapter 40)
• Infrequent dental visits are associated with decreased professional plaque removal, decreased periodontal monitoring, and therefore reduced ability to detect and manage early disease.

7. ADDITIONAL RISK INDICATORS / EMERGING RISK FACTORS

7.1 Obesity and Metabolic Syndrome

• "Recent evidence suggests that obesity, obesity-related characteristics, and metabolic syndrome in particular may be risk indicators for the severity and progression of periodontitis."
• "A systematic review that included the results from five prospective studies evaluating the association between weight gain and the incidence of periodontitis in adults found a clear positive relationship: subjects who became overweight and obese had a higher risk of developing periodontitis when compared with those who did not gain weight."
• "The authors cautioned that the evidence was limited and that more prospective, longitudinal research is needed to establish obesity as a risk factor for periodontitis." - This is precisely why it remains a risk indicator.
• "The association between periodontitis and metabolic syndrome is thought to be the result of systemic oxidative stress and an increased inflammatory response." (Newman & Carranza's 14th Ed., Chapter 25)

• Obesity conferred a 41-72% increased risk for progression of periodontitis after adjustment (Gorman et al. 2012).
• BMI 25-30 kg/m² and ≥30 kg/m² showed statistically higher 5-year incidence of periodontitis (Morita et al. 2011) - establishing a dose-response relationship.

7.2 Female Sex Hormones

• "Adolescents have a higher prevalence of gingivitis than prepubertal children or adults. The rise of sex hormones during adolescence is suspected to be the cause."
• Sex hormones affect the composition of the subgingival microflora.

• "During puberty and pregnancy, these changes are characterized by nonspecific inflammatory reactions with a predominant vascular component, which leads clinically to a marked hemorrhagic tendency."

• "Oral changes during menopause may include thinning of the oral mucosa, gingival recession, xerostomia, altered taste, and burning mouth."
• "Menstrual cycle irregularity is a risk indicator" for periodontal disease. (Newman & Carranza's 14th Ed.)

8. RISK MARKERS / PREDICTORS FOR PERIODONTAL DISEASE

8.1 Previous History of Periodontal Disease

• Presence of previous periodontal disease at baseline can predict further disease progression. (Newman & Carranza's 14th Ed., Chapter 40)
• "The amount of alveolar bone loss or the number of teeth present at baseline may be used to predict further progression of the disease. These variables are, in fact, alternative measures of the disease itself." (Lindhe & Lang, 6th Ed., Chapter 7)

8.2 Bleeding on Probing (BOP)

KEY CLINICAL CORRELATION (Newman & Carranza's 14th Ed., Chapter 40): "Lack of bleeding on probing does appear to serve as an excellent indicator of periodontal health, but the presence of bleeding on probing alone is not a good predictor of future attachment loss."

• BOP is a risk marker/predictor - it is associated with increased risk but does not cause the disease. (Newman & Carranza's 14th Ed., Chapter 40)

9. RISK ASSESSMENT PROCESS

RISK ASSESSMENT PROCESS (Beck 1994)
              |
    __________|__________
    |   STEP 1           |
    |  IDENTIFICATION    |
    |  (Cross-sectional  |
    |  + cohort studies) |
    |  Identify putative |
    |  risk factors      |
    |____________________|
              |
    __________|__________
    |   STEP 2           |
    |  MODELING          |
    |  Assess whether    |
    |  combination of    |
    |  factors predicts  |
    |  health vs disease |
    |____________________|
              |
    __________|__________
    |   STEP 3           |
    |  ASSESSMENT        |
    |  Screen new        |
    |  populations for   |
    |  factor combination|
    |  Compare predicted |
    |  vs actual disease |
    |____________________|
              |
    __________|__________
    |   STEP 4           |
    |  TARGETING         |
    |  Reduce exposure   |
    |  by prevention or  |
    |  intervention;     |
    |  Evaluate effect-  |
    |  iveness           |
    |____________________|

10. HILL'S CRITERIA FOR CAUSAL INFERENCE IN PERIODONTAL RISK FACTOR RESEARCH

11. CLINICAL RISK ASSESSMENT - eBOX 40.1

12. PERIODONTAL RISK CALCULATOR (PRC)

• "PRC is a computer-based risk assessment tool designed to assess the risk of developing periodontitis in those patients who do not have the disease and to assess the risk for disease progression in periodontitis patients."
• "The calculation of risk is a multi-step process involving mathematical algorithms that use nine risk factors:
  1. Age
  2. Smoking history
  3. Diabetes
  4. History of periodontal surgery
  5. Pocket depth
  6. Furcation involvements
  7. Restorations or calculus below the gingival margin
  8. Radiographic bone height
  9. Vertical bone defects"
• "A risk score on a scale of 1 to 5 for periodontal deterioration will be calculated for each patient."
• "The risk score was shown to have a direct correlation with tooth loss in non-periodontitis and periodontitis patients."
• "This tool can provide a more objective, quantitative way to assess risk for periodontitis than clinical opinion."

13. IMPACT OF RISK FACTORS ON SYSTEMIC CONDITIONS

• "It is important to recognize that the systemic diseases, disorders, or conditions themselves do not cause periodontitis; rather, they may predispose, accelerate, or otherwise increase the disease's progression." (Newman & Carranza's 14th Ed., Chapter 25)
• Evidence suggests that "periodontal infections can adversely affect systemic health with manifestations such as coronary heart disease, stroke, diabetes, preterm labor, low-birth-weight delivery, and respiratory disease." (Carranza's 10th Ed., Chapter 17; Newman & Carranza's 14th Ed., Chapter 25)

14. COMPREHENSIVE COMPARISON TABLE: DIFFERING VIEWPOINTS ACROSS REFERENCES

15. SUMMARY FLOWCHART: RISK FACTORS AND PERIODONTAL DISEASE

BACTERIAL CHALLENGE (Prerequisite)
             |
   __________|__________
   |                    |
RISK FACTORS         PROTECTIVE
Modify host           FACTORS
response              (Oral hygiene,
   |                  dental care)
   |
___|___
|     |     |
RISK  RISK  RISK
DETER-INDIC-MARKE
MINA  ATORS RS
NTS
   |
   |→ ALTERED HOST RESPONSE
   |→ Altered immune defense
   |→ Modified tissue response
   |→ Enhanced microbial virulence
             |
    PERIODONTAL DISEASE
    (Gingivitis → Periodontitis)
             |
    _________|_________
    |                  |
TOOTH LOSS       SYSTEMIC
(Ultimate         EFFECTS
consequence)      (CVD, DM, etc.)

1. Newman & Carranza's Clinical Periodontology and Implantology, 14th Ed. - Chapter 40 (Periodontal Risk Assessment), Chapter 25 (Influence of Systemic Conditions), Chapter 6 (Epidemiology Methods)
2. Carranza's Clinical Periodontology, 10th Ed. - Chapter 38 (Risk Factors for Periodontal Disease), Box 38-1, Chapter 17 (Systemic Disorders and Stress)
3. Lindhe & Lang, Clinical Periodontology and Implant Dentistry, 6th Ed. - Chapter 7 (Epidemiology), Chapters 14 and 15 (Risk Factors - Modifying Factors and Host-Parasite Interactions)
4. Oral Epidemiology (Peres, Antunes, Watt, 2021) - Chapter 1 (Cross-sectional studies; sociodemographic risk indicators)

All definitions, classifications, clinical data, and terminology are reproduced directly from the uploaded source texts without paraphrasing or external supplementation.